arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Sanara MedTech Inc.

SMTI
$34.09 ▲ +0.03 (+0.09%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
58 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

Sanara MedTech Inc. faces fundamental challenges with weakness in Profit Margin (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $296.8M
Dividend Yield
Revenue Growth 18.6%
Op. Margin 9.5%
ROIC 3.9%
FCF / Share $-0.29
Trailing P/E 681.8x
Price / Book 44.5x
FCF Yield
Debt / Equity 6.58
info Valuation on last close. End-of-day price, Aug 7, 2026.

58-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$27.80M
↑ +18.6%
Net Income Profit after all expenses
$458.96K
↑ +128.5%
Operating Margin Operating profit as % of sales
9.5%
↑ +149.7% 49th
FCF / Share Free cash flow per share
$-0.29
↑ +33.6%
Long-Term Debt Long-term obligations
$46.23M
↑ +0.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
29
Financial Health
29
Cash Quality
20

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 58 quarters